Skip to main content

Commentaries
About Us
Contact Us
Media Appearances
Follow Us

First-in-Human Trial of a SARS CoV 2 Recombinant Spike Protein Nanoparticle Vaccine

https://www.medrxiv.org/content/10.1101/2020.08.05.20168435v1

Cheryl Keech et al.

medRvx

August 6, 2020

© 2001 — 2025 Trend Macrolytics, LLC. All rights reserved.
For information purposes only, offered as a periodical of general circulation; not to be deemed to be recommendations for buying or selling specific securities or to constitute personalized investment advice. Derived from sources deemed to be reliable, but no warranty is made as to accuracy. Trend Macrolytics, TrendMacro and the stylized triangle symbol are trademarks of Trend Macrolytics, LLC.